Evista and Iron deficiency anaemia - a phase IV clinical study of FDA data

Summary:

Iron deficiency anaemia is found among people who take Evista, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Evista and have Iron deficiency anaemia. It is created by eHealthMe based on reports of 25,183 people who have side effects when taking Evista from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

25,183 people reported to have side effects when taking Evista.
Among them, 52 people (0.21%) have Iron deficiency anaemia.


What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,627 Evista users for its effectiveness, alternative drugs and more.

What is Iron deficiency anaemia?

Iron deficiency anaemia is found to be associated with 1,797 drugs and 1,066 conditions by eHealthMe.

Number of Evista and Iron deficiency anaemia reports submitted per year:

Could Evista cause Iron deficiency anaemia?

Time on Evista when people have Iron deficiency anaemia *:

  • < 1 month: 66.67 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 22.22 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 11.11 %
  • 10+ years: 0.0 %

Gender of people who have Iron deficiency anaemia when taking Evista *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Iron deficiency anaemia when taking Evista *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 15.22 %
  • 60+: 84.78 %

Common drugs people take besides Evista *:

  1. Fosamax: 33 people, 63.46%
  2. Vitamins: 19 people, 36.54%
  3. Zantac: 12 people, 23.08%
  4. Alendronate Sodium: 11 people, 21.15%
  5. Omega-3 Marine Triglycerides: 9 people, 17.31%
  6. Lovaza: 8 people, 15.38%
  7. Actonel: 8 people, 15.38%
  8. Nexium: 6 people, 11.54%
  9. Folic Acid: 6 people, 11.54%
  10. Hydrochlorothiazide: 5 people, 9.62%

Common side effects people have besides Iron deficiency anaemia *:

  1. Femur Fracture: 30 people, 57.69%
  2. Fall: 27 people, 51.92%
  3. Sinusitis (inflammation of sinus): 23 people, 44.23%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 20 people, 38.46%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 20 people, 38.46%
  6. Wax Blockage: 19 people, 36.54%
  7. Low Turnover Osteopathy (slow removal of old bone and its replacement by new bone): 19 people, 36.54%
  8. High Blood Cholesterol: 19 people, 36.54%
  9. Pain In Extremity: 18 people, 34.62%
  10. Intervertebral Disc Degeneration (spinal disc degeneration): 17 people, 32.69%

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 26.92%
  2. High Blood Pressure: 6 people, 11.54%
  3. Hypersensitivity: 4 people, 7.69%
  4. Depression: 3 people, 5.77%
  5. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 5.77%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 5.77%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 5.77%
  8. Diabetes: 2 people, 3.85%
  9. Dizziness: 2 people, 3.85%
  10. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 2 people, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and have Iron deficiency anaemia?

Check whether Iron deficiency anaemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Iron deficiency anaemia and when was it recovered:

Expand to all the drugs that have ingredients of raloxifene hydrochloride:

Alternative drugs to, pros and cons of Evista:

Common Evista side effects:

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Iron deficiency anaemia treatments and more:

COVID vaccines that are related to Iron deficiency anaemia:

Common drugs associated with Iron deficiency anaemia:

All the drugs that are associated with Iron deficiency anaemia:

Common conditions associated with Iron deficiency anaemia:

All the conditions that are associated with Iron deficiency anaemia:

How the study uses the data?

The study uses data from the FDA. It is based on raloxifene hydrochloride (the active ingredients of Evista) and Evista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: